AIDS-CMV retinitis: Singapore's first cases. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS-CMV retinitis: Singapore's first cases.

Ann Acad Med Singapore. 1990 Nov;19(6):781-7. Unique Identifier : AIDSLINE MED/92027425
Law NM; Fan RF; Monterio EH; Department of Ophthalmology, Tan Tock Seng Hospital, Singapore.

Abstract: Since April 1988, four cases of AIDS-CMV retinitis were diagnosed in Singapore. Two patients were given intravenous ganciclovir. Clinical response was good but recurrent episodes of breakthrough infection occurred in one patient despite maintenance therapy. Another patient was started on intravenous foscarnet. The fourth patient succumbed to systemic AIDs-related infection before therapy could be started. AIDS-CMV retinitis is a new disease entity in Singapore. With increasing number of AIDS patients, more cases can be expected in the near future. Early treatment and long term maintenance therapy is essential for preserving sight.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult Case Report Cytomegalovirus/*DRUG EFFECTS Cytomegalovirus Infections/*DRUG THERAPY/EPIDEMIOLOGY Ganciclovir/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/*THERAPEUTIC USE Human Incidence Male Retinitis/*DRUG THERAPY/EPIDEMIOLOGY Singapore/EPIDEMIOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDcomplicationsadultcasereportcytomegalovirus/KWDdrugeffectscytomegalovirusinfections/KWDdrugtherapy/epidemiologyganciclovir/administration&dosage/adverseeffects/KWDtherapeuticusehumanincidencemaleretinitis/KWDdrugtherapy/epidemiologysingapore/epidemiologyjournalarticle
920130
M9210745

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .